Looking to sell Enveda Biosciences stock or options?
Enveda Biosciences has developed a drug analysis platform that leverages the chemical diversity and evolutionary importance of natural samples. By integrating machine learning, metabolomics, and robotics, the company's platform efficiently analyzes natural samples to determine both chemical structures and biological activities. This approach allows healthcare industry clients to identify and characterize a vast array of molecules produced by living organisms without the need for isolating individual compounds or conducting extensive experiments.

Bioverge Ventures, Martin Brenner, Baillie Gifford, Socium Ventures, Dimension (United States), FPV Ventures, True Ventures, JAZZ Venture Partners, Level Ventures, Premji Invest (US).